Edition:
India

Resmed Inc (RMD.N)

RMD.N on New York Stock Exchange

95.42USD
23 Feb 2018
Change (% chg)

$1.64 (+1.75%)
Prev Close
$93.78
Open
$94.49
Day's High
$95.45
Day's Low
$93.51
Volume
145,500
Avg. Vol
208,481
52-wk High
$104.78
52-wk Low
$67.07

Chart for

About

ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD),... (more)

Overall

Beta: 0.77
Market Cap(Mil.): $10,992.71
Shares Outstanding(Mil.): 142.30
Dividend: 0.35
Yield (%): 1.81

Financials

BRIEF-ResMed Q2 Gaap Earnings Per Share $0.07

* ANNOUNCES RESULTS FOR THE SECOND QUARTER OF FISCAL YEAR 2018

23 Jan 2018

NZ's Fisher & Paykel sues Resmed in Australia over patent dispute

New Zealand's Fisher & Paykel Healthcare filed a lawsuit in Australia on Tuesday against Resmed Inc alleging the medical device manufacturer's respiratory treatment products violate four Fisher & Paykel patents.

12 Dec 2017

UPDATE 1-NZ's Fisher & Paykel sues Resmed in Australia over patent dispute

Dec 12 New Zealand's Fisher & Paykel Healthcare filed a lawsuit in Australia on Tuesday against Resmed Inc alleging the medical device manufacturer's respiratory treatment products violate four Fisher & Paykel patents.

12 Dec 2017

NZ's Fisher & Paykel sues Resmed in patent dispute

Dec 12 New Zealand's Fisher & Paykel Healthcare filed a lawsuit in Australia on Tuesday against Resmed Inc alleging the medical device manufacturer's respiratory treatment products violate four Fisher & Paykel patents.

12 Dec 2017

BRIEF-Resmed Inc elects Karen Drexler to its board of directors

* Resmed elects Karen Drexler to its board of directors Source text for Eikon: Further company coverage:

17 Nov 2017

BRIEF-Resmed updates on United Kingdom case with Fisher & Paykel​

* Ruling has no impact on Resmed's commercial operations in UK​

13 Nov 2017

UPDATE 1-Fisher & Paykel says UK court rules rival Resmed's patent is invalid

* UK court rules Resmed's patent for mask invalid - F&P Healthcare

13 Nov 2017

Fisher & Paykel says UK court rules rival Resmed's patent is invalid

WELLINGTON, Nov 13 A British court has ruled that a patent held by health appliance firm Resmed Inc for a mask that treats sleep apnea was invalid, rival firm Fisher & Paykel Healthcare said on Monday.

13 Nov 2017

Earnings vs. Estimates